Follow us at x.com/CleClinicNews
Clinical Guide, and how it is evaluated and treated at Perfect B in Doral
Why claims data alone cant explain real-world GLP-1 outcomes As adoption accelerates, pharmaceutical companies are racing to innovate through new formulations, delivery options, and combination approaches that improve tolerability and long-term outcomes
Buyer Takeaway - On the compounding question: "Not FDA-approved" doesn't mean "unsafe" or "ineffective." It means a different regulatory pathway
Discuss libido changes with your healthcare provider if decreased sexual desire persists for more than 2-4 weeks or affects your quality of life
California will end Medi-Cal coverage for GLP-1 drugs, including Ozempic and Wegovy, starting January 1, 2026, as part of its newly enacted 202526 budget